Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Archaeological research shows that the dispersal of the Neolithic took a more complex turn when reaching western Europe, painting a contrasted picture of interactions between autochthonous hunter-gatherers (HGs) and incoming farmers. In order to clarify the mode, the intensity, and the regional variability of biological exchanges implied in these processes, we report new palaeogenomic data from Occitanie, a key region in Southern France. Genomic data from 28 individuals originating from six sites spanning from c. 5,500 to c. 2,500 BCE allow us to characterize regional patterns of ancestries throughout the Neolithic period. Results highlight major differences between the Mediterranean and Continental Neolithic expansion routes regarding both migration and interaction processes. High proportions of HG ancestry in both Early and Late Neolithic groups in Southern France support multiple pulses of inter-group gene flow throughout time and space and confirm the need for regional studies to address the complexity of the processes involved.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9667241PMC
http://dx.doi.org/10.1016/j.isci.2022.105387DOI Listing

Publication Analysis

Top Keywords

southern france
12
genomic data
8
neolithic
5
neolithic genomic
4
data southern
4
france showcase
4
showcase intensified
4
intensified interactions
4
interactions hunter-gatherer
4
hunter-gatherer communities
4

Similar Publications

Article Synopsis
  • Ataluren was developed to help produce functional proteins in patients with cystic fibrosis caused by nonsense mutations, and this study aimed to assess its effectiveness and safety in such patients.
  • The trial was a randomized, double-blind, placebo-controlled phase 3 study that enrolled 238 patients from 36 sites across North America and Europe, administering ataluren or placebo over 48 weeks.
  • Results showed no significant difference in lung function (FEV1) change or pulmonary exacerbations between ataluren and placebo groups, but a notable improvement was observed in a subgroup of patients not using a specific antibiotic (tobramycin).
View Article and Find Full Text PDF